Individual Study / ATP

Alberta's Tomorrow Project
  1. Home
  2. Individual Studies
  3. ATP

Alberta's Tomorrow Project

ATP logo
Networks -
Datasets -
Variables -
Start Year
2000
Supplementary Information
Visit ATP
Add to cart

Members

Download
Investigators Contacts
  • Dr. Jennifer Vena
    Alberta Health Services - Cancer Care Alberta
  • Dr. Jennifer Vena
    Alberta Health Services - Cancer Care Alberta
  • Alberta's Tomorrow Project
    Research Inquiries & Accessing ATP Data

Design

Study design
Cohort
Follow Up
After baseline (Phase I), participants were followed-up 3 times, in 2004, 2008 and 2017. Follow-ups are planned for at least 50 years.
Supplementary Information

Marker Paper

Ye M, Robson PJ, Eurich DT, et al. Cohort Profile: Alberta's Tomorrow Project. International of Journal Epidemiology, 2017; 46(4):1097-1098

PUBMED 28338725

Recruitment

Recruitment Target
  • Individuals

Number of Participants

Number of Participants
52,810
Number of Participants with Biological Samples
Supplementary Information
Phase I: 31,211 participants
Survey 2004: 9,693 participants
Survey 2008: 20,799 participants
Phase II: 39,418 participants
Follow-up: 33,742 participants
COVID-19: 19,049 participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other
Yes
No
Not applicable
Don't know

Timeline

ATP population

Selection Criteria
Minimum age
35
Maximum age
69
Newborns
Twins
Countries
  • Canada
Territory
Ethnic Origin
Health Status
  • Participants should have no known history of cancer other than non-melanoma skin cancer.

Recruitment

Sources of recruitment
  • General population
General Population
  • Volunteer enrolment
  • Random digit dialing
Supplementary Information
The ATP recruitment was done using a two-stage telephone random digit dialling (RDD) method mapped to Alberta Regional Health Authorities (RHAs). While recruiting new participants in 2009, the RDD method was shortly replaced by the volunteer sampling. Communication and advocating strategies, including the Ambassador Program, media coverage, marketing, advertising, information booths at community events, corporate presentations and articles, were used to promote volunteer recruitment

Number of Participants

Number of Participants
29,878
Number of Participants with Biological Samples
Supplementary Information about selection criteria
Between 2009 and 2015, 23,623 new recruits were enrolled in ATP.
Data Collection Events
# Name Description Start End
0 ATP - Phase I Using the Health and Lifestyle Questionnaire (HLQ), the Canadian Diet History Questionnaire I (CDHQ-I), and the Past-Year Total Physical Activity Questionnaire (PYTPAQ) information was collected ... 2000 2008
1 ATP - Survey 2004 The 2004 survey collected information about general health, personal medical history, lifetime history cancer screening, paps and mammograms, perception of chronic disease risk, reproductive ... 2004 2005
2 ATP - Survey 2008 The 2008 survey collected information about general health, personal medical history, lifetime history, family health history, cancer screening, paps and mammograms, reproductive health, tobacco ... 2008 2009
3 ATP - Phase II Using the Updated Health & Lifestyle Questionnaire (UHLQ) and Physical Activity & Nutrition Survey (PANS) information was collected about general health, personal medical history, lifetime ... 2009 2015
4 ATP - Follow-up The questionnaire collected updated information on participants’ health, including cancers and long-term health conditions, cancer screening, mental health, quality of life, alcohol consumption, ... 2017 2018
5 ATP - COVID-19 Questionnaire Information on COVID-19 test results/suspected infection, symptoms experienced (if any), hospitalizations or received medical care, current health status and risk factors, potential source of ... 2020-07 2020-10

Classifications

Socio-demographic and economic characteristics
Lifestyle and behaviours
Birth, pregnancy and reproductive health history
Perception of health, quality of life, development and functional limitations
Diseases
Symptoms and signs
Medication and supplements
Non-pharmacological interventions
Health and community care services utilization
Death
Physical measures and assessments
Laboratory measures
Cognition, personality and psychological measures and assessments
Life events, life plans, beliefs and values
Preschool, school and work life
Social environment and relationships
Physical environment
Administrative information
Cognitive functioning
Personality
Psychological distress and emotions
Other psychological measures and assessments
Perception of health
Quality of life
Life course development
Functional limitations
Other perception of health, quality of life and functional limitation-related information
Tobacco
Alcohol
Drugs
Nutrition
Breastfeeding
Physical activity
Sleep
Sexual behaviours and orientation
Technological devices
Misbehaviour and criminality
Other and unspecified lifestyle information
Social network
Social participation
Social support
Parenting and familial environment
Other social environment characteristics

Socio-demographic and economic characteristics

Age/birthdate
Sex/gender
Twin
Marital/partner status
Family and household structure
Education
Residence
Birthplace
Citizenship and immigrant status
Ethnicity, race and religion
Language
Labour force and retirement
Income, possessions, and benefits

Lifestyle and behaviours

Tobacco
Alcohol
Nutrition
Breastfeeding
Physical activity
Sleep
Other and unspecified lifestyle information

Birth, pregnancy and reproductive health history

Puberty, menstruation, menopause and andropause
Contraception
Pregnancy, delivery and birth
Fertility and sexual health

Perception of health, quality of life, development and functional limitations

Perception of health
Quality of life
Functional limitations
Use of assistive devices

Diseases

Certain infectious and parasitic diseases (A00-B99)
Neoplasms (C00-D48)
Endocrine, nutritional and metabolic diseases (E00-E90)
Mental and behavioural disorders (F00-F99)
Diseases of the nervous system (G00-G99)
Diseases of the circulatory system (I00-I99)
Diseases of the respiratory system (J00-J99)
Diseases of the digestive system (K00-K93)
Diseases of the skin and subcutaneous tissue (L00-L99)
Diseases of the musculoskeletal system and connective tissue (M00-M99)
Diseases of the genitourinary system (N00-N99)
Diseases without precise specification or falling into multiple categories

Medication and supplements

Medication and supplement intake
Posology and protocol of administration
Other and unspecified pharmacological interventions

Non-pharmacological interventions

Surgical interventions
Radiological interventions
Laboratory diagnosis interventions
Other and unspecified non-pharmacological interventions

Health and community care services utilization

Visits to health professionals
Other health and community care

Death

Vital status

Physical measures and assessments

Physical characteristics
Anthropometry
Circulation and respiration
Muscles, skeleton and mobility
Other physical measures and assessments

Cognition, personality and psychological measures and assessments

Psychological distress and emotions

Life events, life plans, beliefs and values

Beliefs and values

Preschool, school and work life

Work life

Social environment and relationships

Social network
Social participation
Social support

Physical environment

Housing characteristics
Built environment/neighbourhood characteristics
Radiation exposure
Chemical exposure

Administrative information

Identifiers
Questionnaire and interview-related information
Physical and cognitive measure and biosample-related information
Other administrative information

Psychological distress and emotions

Chronic Stress Scale

Quality of life

Short-Form 36 Health Survey

Nutrition

Canadian Diet History Questionnaire

Physical activity

International Physical Activity Questionnaire
Past Year Total Physical Activity Questionnaire

Social support

Medical Outcomes Study Social Support Survey